Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma

Matteo Costacurta; Stephin J. Vervoort; Simon J. Hogg; Benjamin P. Martin; Ricky W. Johnstone; Jake Shortt

doi:10.3324/haematol.2020.265611

Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma

Matteo Costacurta
, Stephin J. Vervoort
, Simon J. Hogg
, Benjamin P. Martin
, Ricky W. Johnstone
, Jake Shortt

Medicine Monash Health

Research output: Contribution to journal › Letter › Research › peer-review

10 Citations (Scopus)

Abstract

Original language	English
Pages (from-to)	2013-2017
Number of pages	5
Journal	Haematologica
Volume	106
Issue number	7
DOIs	https://doi.org/10.3324/haematol.2020.265611
Publication status	Published - Jul 2021

Access to Document

10.3324/haematol.2020.265611

Cite this

@article{76d1f4f5c7ee493aa9d6f29ada630725,

title = "Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma",

author = "Matteo Costacurta and Vervoort, \{Stephin J.\} and Hogg, \{Simon J.\} and Martin, \{Benjamin P.\} and Johnstone, \{Ricky W.\} and Jake Shortt",

year = "2021",

month = jul,

doi = "10.3324/haematol.2020.265611",

language = "English",

volume = "106",

pages = "2013--2017",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Fondazione Ferrata Storti",

number = "7",

}

TY - JOUR

T1 - Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma

AU - Costacurta, Matteo

AU - Vervoort, Stephin J.

AU - Hogg, Simon J.

AU - Martin, Benjamin P.

AU - Johnstone, Ricky W.

AU - Shortt, Jake

PY - 2021/7

Y1 - 2021/7

UR - https://www.scopus.com/pages/publications/85099115233

U2 - 10.3324/haematol.2020.265611

DO - 10.3324/haematol.2020.265611

M3 - Letter

C2 - 33375771

AN - SCOPUS:85099115233

SN - 0390-6078

VL - 106

SP - 2013

EP - 2017

JO - Haematologica

JF - Haematologica

IS - 7

ER -

Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma

Abstract

Access to Document

Other files and links

Cite this